ADVI
ADVI Health is a Washington, DC-based boutique healthcare advisory firm providing market access, reimbursement, policy, and data analytics consulting to pharmaceutical, biotech, medical device, diagnostics, and digital health companies across the product lifecycle.
- Company typePrivate
- Founded2000
- HeadquartersWashington, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ADVI does
ADVI (operating as ADVI Health) is a Washington, DC-based boutique healthcare advisory firm founded in 2000 that provides strategic consulting to life sciences companies navigating commercialization, market access, reimbursement, and federal/state policy. The firm serves pharmaceutical, biotechnology, medical device, diagnostics, digital health, and physician practice clients across the product lifecycle, with named service lines spanning Policy, Research, and Analysis; Market Access; Coding and Reimbursement; Strategic Analytics, Value and Economics (SAVEs); and Financial Services Due Diligence. Its claimed point of differentiation is being quicker, more in-depth, and more available than larger consultancies, anchored by a senior team that includes former congressional staffers (e.g., The McManus Group alumni), ex-Moran Company Medicare payment experts, and operators from Exact Sciences and KFF.
The firm's technology backbone combines proprietary healthcare claims analytics with structured consulting IP. ADVI holds a CMS Virtual Research Data Center (VRDC) innovator license providing direct access to 100% Medicare FFS claims and the 100% T-MSIS Medicaid claims database, feeding the ADVI Databoard — a client-facing analytics dashboard for drug utilization, reimbursement trends, and market dynamics. A second productized offering, RAND/UCLA Modified Delphi Panels, is a four-phase structured consensus methodology used for HEOR, market access, and payer-focused evidence generation. The August 2024 acquisition of Partnership for Health Analytic Research (PHAR) added dedicated health technology assessment and HEOR research capacity.
ADVI generates revenue primarily through professional consulting engagements (project-based, custom-quoted) supplemented by ADVI Angle, a subscription-based email newsletter launched in August 2023. The firm operates a sales-led, direct enterprise GTM motion with senior team members generating leads at industry conferences (AMCP, ISPOR, Asembia, Informa) and publishing in-depth analysis through its Insights hub and earned media in CNBC, Bloomberg Law, Fierce Healthcare, and the Wall Street Journal. The firm remains privately held under founder/CEO Marc Samuels, JD, MPH, with no disclosed external funding rounds.
ADVI firmographics
Firmographics- Name
- ADVI
- Legal name
- ADVI
- Website
- https://advi.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ADVI Health is a Washington, DC-based boutique healthcare advisory firm providing market access, reimbursement, policy, and data analytics consulting to pharmaceutical, biotech, medical device, diagnostics, and digital health companies across the product lifecycle.
- Ownership category
- akta.pro rank
ADVI industry classification
Industry- Product category
- Healthcare Consulting Services
- NAICS
- Advertising, Public Relations, and Related Services (5418), Advertising Agencies (54181)
- SIC
- Services-Advertising Agencies (7311), Services-Health Services (8000)
- akta.pro primary industry
- Patient Feedback, Surveys, Reputation & Experience Measurement (VoC) (HLACAEAH)
Keywords
Where ADVI is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ADVI business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Strategic Consulting Services: ADVI generates revenue through professional consulting engagements with life sciences companies seeking market access, policy, and commercialization expertise. Services include customized analysis, regulatory guidance, and strategic advisory engagements.
- Subscription Content (ADVI Angle): ADVI Angle is a subscription-based email series providing exclusive insights and analytics on healthcare topics including IRA, cell and gene therapy, oncology reimbursement, and market access. Delivered as periodic email communications.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
ADVI product offering
Product offeringCore offering
ADVI Health is a strategic consulting firm that helps life sciences companies solve commercialization, market access, reimbursement, and policy challenges. It combines expert advisory services with data-informed analytics, including proprietary Medicare/Medicaid claims datasets and the ADVI Databoard, to support pharmaceutical, biotech, medical device, and digital health clients across the product lifecycle.
Product overview
ADVI Health is a strategic consulting firm offering advisory services across the healthcare and life sciences ecosystem. The portfolio includes four core solution areas: Policy, Research, and Analysis; Market Access; Reimbursement; and Strategic Analytics, Value and Economics (SAVEs). Supporting these are specialized data products like the ADVI Databoard for real-time analytics, and research methodologies including RAND/UCLA Modified Delphi Panels for expert consensus generation. The ADVI Angle email series delivers expert insights on key healthcare topics. All offerings are delivered through experienced consulting professionals combining market access expertise, former policymaker backgrounds, and industry veteran knowledge.
Differentiator
Problem solved
Functional benefit
Brands
- ADVI Angle: A comprehensive email series providing timely updates and expert insights on crucial healthcare issues including IRA analytics, cell and gene therapy evolution, oncology reimbursement, and market access.
Products and services
- Market Access and Pricing Strategy
- Policy, Research, and Analysis
- Strategic Analytics, Value and Economics (SAVEs)
- Coding and Reimbursement
- Financial Services Due Diligence
- ADVI Databoard
- ADVI Angle Subscription email series delivering exclusive insights and analytics on healthcare topics including IRA analytics, cell and gene therapy evolution, oncology reimbursement, health policy dynamics, and market access trends.
- RAND/UCLA Modified Delphi Panels
Quantifiable outcome
- ADVI analysis found that Medicare expenditure for beneficiaries diagnosed with rare diseases was over 3x higher than those without, affecting approximately 3.5 million beneficiaries with 379 rare diseases identified in Medicare FFS population (2022 data)
- +1 more outcomes
Companies that use ADVI
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles5 records
ADVI technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
ADVI partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights6 records
ADVI competitors and assessment
Company assessmentBroad incumbents
- IQVIA: IQVIA is the largest global life sciences services firm, offering market access, real-world evidence, policy analytics, and consulting as part of a much broader portfolio. It competes with ADVI on enterprise-level market access and policy engagements and has the scale to out-resource boutique competitors on multi-region programs.
- Kantar (Health Division): Kantar Health provides real-world evidence, HEOR, and market access advisory services as part of its broader commercial and consumer health portfolio. It competes with ADVI on payer evidence and reimbursement strategy work for global life sciences clients.
- McKinsey & Company (Pharma and Medical Products Practice): McKinsey's pharma and medical products practice includes market access, pricing, and policy advisory work for global life sciences companies. It competes with ADVI on enterprise strategy engagements, particularly at the top end of pharma where scale and global reach dominate selection criteria.
Direct peers
- Avalere Health: Avalere is a Washington, DC-based healthcare policy and market access consulting firm serving life sciences companies, payers, and providers. It is the closest direct competitor to ADVI in policy advisory, reimbursement strategy, and federal health program analysis, with comparable CMS/FDA expertise and overlapping client bases.
- Analysis Group: Analysis Group is a leading economics and health economics consulting firm with a substantial HEOR practice serving pharmaceutical and biotech clients. It directly competes with ADVI on health economics studies, claims data analyses, and payer evidence generation engagements.
- ZS Associates: ZS is a global management consulting firm with a large pharma and biotech practice focused on market access, pricing, and commercialization strategy. It competes with ADVI on enterprise market access engagements and shares ADVI's life sciences customer base, though ZS operates at significantly greater scale.
- Precision Medicine Group: Precision Medicine Group provides commercialization, market access, and HEOR services to biopharma and diagnostics clients. It overlaps directly with ADVI's reimbursement, market access, and value strategy offerings for similar customer profiles.
- Evidera (PPD, Thermo Fisher Scientific): Evidera is a dedicated HEOR, market access, and real-world evidence consultancy within PPD. It competes directly with ADVI on health economics, patient-reported outcomes, and reimbursement evidence work, and is a logical competitor following ADVI's PHAR acquisition.
- Charles River Associates: CRA's Life Sciences practice provides health economics, market access, and policy consulting to pharma and biotech clients. It directly overlaps with ADVI's HEOR, reimbursement, and policy offerings and serves many of the same enterprise customers with comparable analytical methodologies.
- Trinity Life Sciences: Trinity Life Sciences provides commercial strategy, market access, and HEOR consulting to pharmaceutical and biotech clients. It directly competes with ADVI on commercialization strategy and value demonstration work for the same enterprise customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights3 records
Customer concentration
ADVI social profiles
Digital presenceADVI financial estimates
Financial estimateRevenue estimate
Valuation estimate
ADVI leadership team
Management profileNumber of profiles
Profiles17 records
ADVI subsidiaries and ownership
Company hierarchySubsidiaries1 record
ADVI funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ADVI M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ADVI
What does ADVI do?
ADVI Health is a strategic consulting firm that helps life sciences companies solve commercialization, market access, reimbursement, and policy challenges. It combines expert advisory services with data-informed analytics, including proprietary Medicare/Medicaid claims datasets and the ADVI Databoard, to support pharmaceutical, biotech, medical device, and digital health clients across the product lifecycle.
Is ADVI a public or private company?
ADVI is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ADVI founded?
ADVI was founded in 2000. It employs 11 to 50 people.
Where is ADVI based?
ADVI is headquartered in Washington, United States, in the North America region.
How does ADVI make money?
Two revenue lines are on record. Strategic Consulting Services are the primary driver. The others are subscription Content (ADVI Angle).
Who are ADVI's main competitors?
Broad incumbents on record are IQVIA, Kantar (Health Division) and McKinsey & Company (Pharma and Medical Products Practice). Direct peers are Avalere Health, Analysis Group, ZS Associates, Precision Medicine Group, Evidera (PPD, Thermo Fisher Scientific), Charles River Associates and Trinity Life Sciences.
Does ADVI have an API?
No public API is recorded for ADVI.
What industry is ADVI in?
ADVI's product category is Healthcare Consulting Services. Its primary akta.pro industry code is HLACAEAH, Patient Feedback, Surveys, Reputation & Experience Measurement (VoC). Its NAICS code is 5418 and its SIC code is 7311.